Skip to main content

Table 2 Univariate GEE*ϕ analysis of sociodemographic, behavioural and clinical factors associated with ≥ 95% ART adherence.

From: Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare

Variable OR (95% CI) p-value
Gender    
   (Female vs. Male) 0.69 (0.52-0.90) 0.006
Age    
   (<24 yrs vs. ≥ 24 yrs) 0.16 (0.08-0.31) <0.001
Ethnicity    
   (Aboriginal vs. other) 0.97 (0.74-1.28) 0.841
Heroin use*    
   (Daily vs. not daily) 0.38 (0.30-0.48) <0.001
Cocaine use*    
   (Daily vs. not daily) 0.48 (0.40-0.57) <0.001
Crack use*    
   (Daily vs. not daily) 0.94 (0.78-1.13) 0.509
Methadone treatment    
   (Yes vs. no) 2.44 (2.01-2.96) <0.001
Other addiction treatment    
   (Yes vs. no) 1.50 (1.26-1.79) <0.001
Education    
   (less than highschool vs. other) 0.56 (0.37-0.85) 0.007
Employment    
   (reg job, temp work, self-emp vs. other) 1.11 (0.87-1.41) 0.401
Unstable housing    
   (Yes vs. no) 0.90 (0.76-1.07) 0.239
Viral load    
   (per log10copies/mL) 0.54 (0.48-0.60) <0.001
CD4+ count    
   (per 100 cells/mm3) 0.95 (0.89-1.00) 0.047
  1. *Refers to the previous six-month period. Defined as drug treatment other than methadone in the past six months. ϕGEE = Generalized Estimating Equation.